Multi-omics integration of scRNA-seq time series data predicts new intervention points for Parkinson's disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 05 2024
Historique:
received: 30 01 2024
accepted: 10 05 2024
medline: 15 5 2024
pubmed: 15 5 2024
entrez: 14 5 2024
Statut: epublish

Résumé

Parkinson's disease (PD) is a complex neurodegenerative disorder without a cure. The onset of PD symptoms corresponds to 50% loss of midbrain dopaminergic (mDA) neurons, limiting early-stage understanding of PD. To shed light on early PD development, we study time series scRNA-seq datasets of mDA neurons obtained from patient-derived induced pluripotent stem cell differentiation. We develop a new data integration method based on Non-negative Matrix Tri-Factorization that integrates these datasets with molecular interaction networks, producing condition-specific "gene embeddings". By mining these embeddings, we predict 193 PD-related genes that are largely supported (49.7%) in the literature and are specific to the investigated PINK1 mutation. Enrichment analysis in Kyoto Encyclopedia of Genes and Genomes pathways highlights 10 PD-related molecular mechanisms perturbed during early PD development. Finally, investigating the top 20 prioritized genes reveals 12 previously unrecognized genes associated with PD that represent interesting drug targets.

Identifiants

pubmed: 38744869
doi: 10.1038/s41598-024-61844-3
pii: 10.1038/s41598-024-61844-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

10983

Subventions

Organisme : European Union's EU Framework Programme for Research and Innovation Horizon 2020
ID : 860895
Organisme : European Research Council (ERC) Consolidator Grant
ID : 770827
Organisme : Spanish State Research Agency and the Ministry of Science and Innovation MCIN grant
ID : PID2019-105500GB-I00 / AEI / 10.13039/501100011033
Organisme : Department of Research and Universities of the Generalitat de Catalunya
ID : 2021 SGR 01536
Organisme : PRIDE program of the Luxembourg National Research Fund
ID : PRIDE17/12244779/PARK-QC

Informations de copyright

© 2024. The Author(s).

Références

Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Primers 3, 1–21 (2017).
doi: 10.1038/nrdp.2017.13
Yang, W. et al. Current and projected future economic burden of Parkinson’s disease in the us. NPJ Parkinson’s Dis. 6, 1–9 (2020).
Balestrino, R. & Schapira, A. Parkinson disease. Eur. J. Neurol. 27, 27–42 (2020).
pubmed: 31631455 doi: 10.1111/ene.14108
Giguère, N., Burke Nanni, S. & Trudeau, L. E. On cell loss and selective vulnerability of neuronal populations in Parkinson’s disease. Front. Neurol. 9, 383041 (2018).
doi: 10.3389/fneur.2018.00455
Lee, J., Hyeon, D. Y. & Hwang, D. Single-cell multiomics: Technologies and data analysis methods. Exp. Mol. Med. 52, 1428–1442 (2020).
pubmed: 32929225 pmcid: 8080692 doi: 10.1038/s12276-020-0420-2
Smajić, S. et al. Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state. Brain 145, 964–978 (2022).
pubmed: 34919646 doi: 10.1093/brain/awab446
Novak, G. et al. Single-cell transcriptomics of human IPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease. Commun. Biol. 5, 1–19 (2022).
doi: 10.1038/s42003-021-02973-7
Luecken, M. D. et al. Benchmarking atlas-level data integration in single-cell genomics. Nat. Methods 19, 41–50 (2022).
pubmed: 34949812 doi: 10.1038/s41592-021-01336-8
Luecken, M. D. & Theis, F. J. Current best practices in single-cell rna-seq analysis: A tutorial. Mol. Syst. Biol. 15, e8746 (2019).
pubmed: 31217225 pmcid: 6582955 doi: 10.15252/msb.20188746
Welch, J. D. et al. Single-cell multi-omic integration compares and contrasts features of brain cell identity. Cell 177, 1873–1887 (2019).
pubmed: 31178122 pmcid: 6716797 doi: 10.1016/j.cell.2019.05.006
Thygesen, C., Boll, I., Finsen, B., Modzel, M. & Larsen, M. R. Characterizing disease-associated changes in post-translational modifications by mass spectrometry. Expert Rev. Proteom. 15, 245–258 (2018).
doi: 10.1080/14789450.2018.1433036
Jung, I., Choi, J. & Chae, H. A non-negative matrix factorization-based framework for the analysis of multi-class time-series single-cell rna-seq data. IEEE Access 8, 42342–42348 (2020).
doi: 10.1109/ACCESS.2020.2977106
Yang, J., Yang, S., Fu, Y., Li, X. & Huang, T. Non-negative graph embedding. In 2008 IEEE Conference on Computer Vision and Pattern Recognition, 1–8 (IEEE, 2008).
Huizing, G.-J., Deutschmann, I. M., Peyré, G. & Cantini, L. Paired single-cell multi-omics data integration with Mowgli. Nat. Commun. 14(1), 7711 (2023).
pubmed: 38001063 pmcid: 10673889 doi: 10.1038/s41467-023-43019-2
Argelaguet, R. et al. Mofa+: A statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 21, 1–17 (2020).
doi: 10.1186/s13059-020-02015-1
Hwang, T. et al. Co-clustering phenome-genome for phenotype classification and disease gene discovery. Nucl. Acids Res. 40, e146–e146 (2012).
pubmed: 22735708 pmcid: 3479160 doi: 10.1093/nar/gks615
Malod-Dognin, N. et al. Towards a data-integrated cell. Nat. Commun. 10, 1–13 (2019).
Peng, W., Li, L., Dai, W., Du, J. & Lan, W. Predicting protein functions through non-negative matrix factorization regularized by protein-protein interaction network and gene functional information. In 2019 IEEE International Conference on Bioinformatics and Biomedicine, 86–89 (IEEE, 2019).
Tang, X. et al. Indicator regularized non-negative matrix factorization method-based drug repurposing for covid-19. Front. Immunol. 11, 3824 (2021).
doi: 10.3389/fimmu.2020.603615
Elyanow, R., Dumitrascu, B., Engelhardt, B. E. & Raphael, B. J. NETNMF-SC: Leveraging gene-gene interactions for imputation and dimensionality reduction in single-cell expression analysis. Genome Res. 30, 195–204 (2020).
pubmed: 31992614 pmcid: 7050525 doi: 10.1101/gr.251603.119
Kunes, R. Z., Walle, T., Land, M., Nawy, T. & Pe’r, D. Supervised discovery of interpretable gene programs from single-cell data. Nat. Biotechnol. 21, 1–12 (2023).
Li, M. M. et al. Contextualizing protein representations using deep learning on protein networks and single-cell data. bioRxiv (2023).
Anandhan, A. et al. Metabolic dysfunction in Parkinson’s disease: Bioenergetics, redox homeostasis and central carbon metabolism. Brain Res. Bull. 133, 12–30 (2017).
pubmed: 28341600 pmcid: 5555796 doi: 10.1016/j.brainresbull.2017.03.009
Oughtred, R. et al. The biogrid interaction database: 2019 update. Nucl. Acids Res. 47, D529–D541 (2019).
pubmed: 30476227 doi: 10.1093/nar/gky1079
Obayashi, T., Kagaya, Y., Aoki, Y., Tadaka, S. & Kinoshita, K. Coxpresdb v7: A gene coexpression database for 11 animal species supported by 23 coexpression platforms for technical evaluation and evolutionary inference. Nucl. Acids Res. 47, D55–D62 (2019).
pubmed: 30462320 doi: 10.1093/nar/gky1155
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. Kegg: New perspectives on genomes, pathways, diseases and drugs. Nucl. Acids Res. 45, D353–D361 (2017).
pubmed: 27899662 doi: 10.1093/nar/gkw1092
Ashburner, M. et al. Gene ontology: Tool for the unification of biology. Nat. Genet. 25, 25–29 (2000).
pubmed: 10802651 pmcid: 3037419 doi: 10.1038/75556
Jassal, B. et al. The reactome pathway knowledgebase. Nucl. Acids Res. 48, D498–D503 (2020).
pubmed: 31691815
Pedregosa, F. et al. Scikit-learn: Machine learning in python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
Ghemrawi, R. & Khair, M. Endoplasmic reticulum stress and unfolded protein response in neurodegenerative diseases. Int. J. Mol. Sci. 21, 6127 (2020).
pubmed: 32854418 pmcid: 7503386 doi: 10.3390/ijms21176127
Dong, C. et al. Plasma metabolite signature classifies male lrrk2 Parkinson’s disease patients. Metabolites 12, 149 (2022).
pubmed: 35208223 pmcid: 8876175 doi: 10.3390/metabo12020149
Figura, M. et al. Serum amino acid profile in patients with Parkinson’s disease. PLoS One. 13(1), e0191670 (2018).
pubmed: 29377959 pmcid: 5788376 doi: 10.1371/journal.pone.0191670
Chi, J. et al. Integrated analysis and identification of novel biomarkers in Parkinson’s disease. Front. Aging Neurosci. 18(10), 178 (2018).
doi: 10.3389/fnagi.2018.00178
Roussel, B. D. et al. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 12, 105–118 (2013).
pubmed: 23237905 doi: 10.1016/S1474-4422(12)70238-7
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. Roy. Stat. Soc. Ser. B Methodol. 57, 289–300 (1995).
doi: 10.1111/j.2517-6161.1995.tb02031.x
Teyssou, E. et al. The amyotrophic lateral sclerosis m114t pfn1 mutation deregulates alternative autophagy pathways and mitochondrial homeostasis. Int. J. Mol. Sci. 23, 5694 (2022).
pubmed: 35628504 pmcid: 9143529 doi: 10.3390/ijms23105694
Organization, W.H. Guidelines for the treatment of malaria (World Health Organization, 2015).
Gao, Y. et al. Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the pi3k/akt pathway. Metab. Brain Dis. 35, 661–672 (2020).
pubmed: 32152798 doi: 10.1007/s11011-020-00533-2
Rai, S. N. et al. The role of pi3k/akt and ERK in neurodegenerative disorders. Neurotox. Res. 35, 775–795 (2019).
pubmed: 30707354 doi: 10.1007/s12640-019-0003-y
Singh, S. S. et al. Nf-κb-mediated neuroinflammation in Parkinson’s disease and potential therapeutic effect of polyphenols. Neurotox. Res. 37, 491–507 (2020).
pubmed: 31823227 doi: 10.1007/s12640-019-00147-2
Sikora, J. & Ouagazzal, A.-M. Synaptic zinc: An emerging player in Parkinson’s disease. Int. J. Mol. Sci. 22, 4724 (2021).
pubmed: 33946908 pmcid: 8125092 doi: 10.3390/ijms22094724
Wishart, D. S. et al. Drugbank 5.0: a major update to the Drugbank database for 2018. Nucleic Acids Res. 46, D1074–D1082 (2018).
pubmed: 29126136 doi: 10.1093/nar/gkx1037
Wishart, D. S. et al. Hmdb 5.0: The human metabolome database for 2022. Nucl. Acids Res. 50, D622–D631 (2022).
pubmed: 34986597 doi: 10.1093/nar/gkab1062
Fujita, K. A. et al. Integrating pathways of Parkinson’s disease in a molecular interaction map. Mol. Neurobiol. 49, 88–102 (2014).
pubmed: 23832570 doi: 10.1007/s12035-013-8489-4
Travaglio, M. et al. Increased cysteine metabolism in pink1 models of Parkinson’s disease. Dis. Models Mech. 16, 049727 (2023).
doi: 10.1242/dmm.049727
Kim, K.-H. & Son, J. H. Pink1 gene knockdown leads to increased binding of parkin with actin filament. Neurosci. Lett. 468, 272–276 (2010).
pubmed: 19909785 doi: 10.1016/j.neulet.2009.11.011
Requejo-Aguilar, R. et al. Pink1 deficiency sustains cell proliferation by reprogramming glucose metabolism through hif1. Nat. Commun. 5, 4514 (2014).
pubmed: 25058378 doi: 10.1038/ncomms5514
Azkona, G. et al. Lrrk2 expression is deregulated in fibroblasts and neurons from Parkinson patients with mutations in pink1. Mol. Neurobiol. 55, 506–516 (2018).
pubmed: 27975167 doi: 10.1007/s12035-016-0303-7
Shah, K. & Rossie, S. Tale of the good and the bad cdk5: Remodeling of the actin cytoskeleton in the brain. Mol. Neurobiol. 55, 3426–3438 (2018).
pubmed: 28502042 doi: 10.1007/s12035-017-0525-3
Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303
Lopes, F. M., Bristot, I. J., Da Motta, L. L., Parsons, R. B. & Klamt, F. Mimicking Parkinson’s disease in a dish: Merits and pitfalls of the most commonly used dopaminergic in vitro models. NeuroMol. Med. 19, 241–255 (2017).
doi: 10.1007/s12017-017-8454-x
Brunet, J.-P., Tamayo, P., Golub, T. R. & Mesirov, J. P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl. Acad. Sci. 101, 4164–4169 (2004).
pubmed: 15016911 pmcid: 384712 doi: 10.1073/pnas.0308531101
Vavasis, S. A. On the complexity of nonnegative matrix factorization. SIAM J. Optim. 20, 1364–1377 (2010).
doi: 10.1137/070709967
Ding, C., Li, T., Peng, W. & Park, H. Orthogonal nonnegative matrix t-factorizations for clustering. In Proceedings of the 12th ACM SIGKDD International Conference on Knowledge Discovery and Data mining, 126–135 (2006).
Qiao, H. New svd based initialization strategy for non-negative matrix factorization. Pattern Recogn. Lett. 63, 71–77 (2015).
doi: 10.1016/j.patrec.2015.05.019
Gligorijević, V., Malod-Dognin, N. & Pržulj, N. Patient-specific data fusion for cancer stratification and personalised treatment. In Biocomputing 2016: Proceedings of the Pacific Symposium, 321–332 (World Scientific, 2016).
Li, B. et al. Gene4PD: A comprehensive genetic database of Parkinson’s disease. Front. Neurosci. 15, 679568 (2021).
pubmed: 33981200 pmcid: 8107430 doi: 10.3389/fnins.2021.679568
Mihajlovic, K. KatarinaMihajlovic/NetSCNMTF-2stepmining: NetSCNMTF-2stepmining_DOI, https://doi.org/10.5281/zenodo.10391383 , https://doi.org/10.5281/zenodo.10391383 (2023).

Auteurs

Katarina Mihajlović (K)

Barcelona Supercomputing Center (BSC), 08034, Barcelona, Spain.

Gaia Ceddia (G)

Barcelona Supercomputing Center (BSC), 08034, Barcelona, Spain.

Noël Malod-Dognin (N)

Barcelona Supercomputing Center (BSC), 08034, Barcelona, Spain.

Gabriela Novak (G)

The Integrative Cell Signalling Group, Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.

Dimitrios Kyriakis (D)

The Integrative Cell Signalling Group, Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.

Alexander Skupin (A)

The Integrative Cell Signalling Group, Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.
University of California San Diego, La Jolla, CA, 92093, USA.

Nataša Pržulj (N)

Barcelona Supercomputing Center (BSC), 08034, Barcelona, Spain. natasha@bsc.es.
Department of Computer Science, University College London, WC1E 6BT, London, UK. natasha@bsc.es.
ICREA, Pg. Lluís Companys 23, 08010, Barcelona, Spain. natasha@bsc.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH